Physician profile
James P Sutherland
NPI 1619965589
$2,449.06
in general payments reported to CMS, 2019-2025
18 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $408 · 2021: $377 · 2022: $110 · 2023: $599 · 2024: $140 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $962.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $706.71 | 2019-2025 | Real Intelligence, Journey II, Pico 14 |
| Depuy Synthes Sales INC. | $555.93 | 2019-2025 | |
| Si-Bone, INC. | $407.59 | 2020 | |
| Zimmer Biomet Holdings, INC. | $105.83 | 2021 | |
| Ferring Pharmaceuticals INC. | $97.12 | 2023-2024 | Euflexxa |
| Exactech, INC. | $89.30 | 2023 | |
| Ethicon US, LLC | $72.42 | 2024 | Stratafix, Dermabond, Surgiflo Hemostatic Matrix |
| Vertex Pharmaceuticals Incorporated | $64.46 | 2025 | |
| Pfizer INC. | $63.12 | 2023 | |
| Integra Lifesciences Corporation | $58.27 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bioventus LLC | $51.33 | 2019-2023 | Durolane |
| Pacira Pharmaceuticals Incorporated | $48.26 | 2022-2025 | Exparel |
| Pacira Therapeutics, INC. | $36.71 | 2019-2021 | |
| Baxter Healthcare | $30.55 | 2019 | |
| Becton, Dickinson and Company | $20.08 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.56 | 2023 | Evenity, Prolia |
| Kci USA, INC. | $15.14 | 2019 | |
| Orthofix Medical, INC. | $9.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Sutherland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.